Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
32.97
+0.15 (0.44%)
Feb 11, 2026, 4:00 PM EST - Market closed

Immunocore Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1,6641,4763,3782,7341,501-
Market Cap Growth
3.67%-56.30%23.54%82.12%--
Enterprise Value
1,2071,0563,0192,4301,242-
Last Close Price
32.9329.5068.3257.0734.24-
PS Ratio
4.364.7613.5415.6841.15-
PB Ratio
4.194.099.168.076.46-
P/TBV Ratio
4.204.099.168.076.46-
P/FCF Ratio
564.4470.66----
P/OCF Ratio
208.2056.641148.85---
EV/Sales Ratio
3.183.4012.1113.9334.05-
EV/FCF Ratio
409.5950.54----
Debt / Equity Ratio
1.101.200.230.240.371.15
Debt / FCF Ratio
147.8520.72----
Asset Turnover
0.350.390.440.370.110.16
Inventory Turnover
8.892.112.89---
Quick Ratio
5.684.263.634.564.172.66
Current Ratio
6.004.383.804.704.292.78
Return on Equity (ROE)
-7.55%-14.01%-15.62%-18.40%-117.20%-211.34%
Return on Assets (ROA)
-1.55%-4.08%-6.73%-6.91%-32.31%-29.00%
Return on Invested Capital (ROIC)
---416.02%-713.57%--
Return on Capital Employed (ROCE)
-2.90%-6.60%-13.20%-12.10%-53.60%-62.50%
Earnings Yield
-1.76%-3.46%-1.64%-1.92%-11.99%-
FCF Yield
0.18%1.42%-0.07%-1.88%-9.63%-
Buyback Yield / Dilution
-0.69%-2.25%-6.94%-7.59%-60.19%-18.95%
Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q